Professional specialized study sites in Germany

Over the last several years, Germany has developed into one of the most important markets for the pharmaceutical industry worldwide. In general, this does not only apply to regular medical care but also to the awarding and conducting of clinical trials.

For industry-sponsored clinical trials Germany has become the second most important country worldwide. But it turns out that other countries are not inferior in terms of professionalism and implementation in the field of clinical drug research. (Source: vfa.de)

Germany should and must continue to strengthen its position as a market for the pharmaceutical industry. A first step is to give physicians and patients the chance of modern medicine by resolving or reducing bureaucratic hurdles in the approval process of clinical trials. This path is increasingly being taken.

Our ambitious target is to become the largest and most successful network of study sites in Germany and to expand internationally. We work to ensure the highest level of service for our study sites and to offer our sponsors and CROs highly qualified and highly motivated study sites. Your project becomes our project and this a common success. Together we are strong!